HOME >> BIOLOGY >> NEWS
SNM 'capitalizes' opportunity to meet with policymakers, regulators at annual meeting in D.C.

tiatives," 12:302 p.m., June 4 Thomas B. Valuck, medical officer and senior adviser to the director of Center for Medicare Management at CMS, who advises on clinical and policy issues related to Medicare's payment systems, will present "CMS Pay for Performance and Quality Initiatives" from 12:301:30 p.m.

  • Food and Drug Administration: "Research With Radiolabeled Drugs," 4:306 p.m., June 4

  • Nuclear Regulatory Commission: "NRC: Running an NRC-Compliant Radiation Safety Program," 9:4511:15 a.m., June 5

  • Capitol Hill Day: Molecular Imaging and the Public Policy Agenda: 11 a.m.3 p.m., June 5

  • Food and Drug Administration: "Final PET Drug Current Good Manufacturing Process (CGMP)" (tentative), 89:30 a.m., June 6

Researcherscovering the most recent advances in understanding, diagnosing and treating heart and brain diseases and cancerrelease their findings in nearly 1,800 scientific abstracts during SNM's 54th Annual Meeting June 26 at the Washington Convention Center. More than 4,000 physicians, technologists, scientists and pharmacists will attend this meeting, the world's largest event for molecular imaging and nuclear medicine professionals. The educational and scientific program at the 54th Annual Meeting is tailored to provide attendees with the most current and important information available in the field. SNM and SNMTS present about 100 continuing education courses focusing on PET/CT, cardiovascular nuclear medicine, brain imaging, pediatrics, oncology and therapy, thyroid cancer and radiation safety.

To register for the meeting, visit the SNM Web site at http://www.snm.org/am. Press registration is complimentary to credentialed media. For press registration only, contact Maryann Verrillo, at (703) 652-6773 or mverrillo@snm.org. Press representatives may also register online at

Contact: Maryann Verrillo
mverrillo@snm.org
703-652-6773
Society of Nuclear Medicine
2-May-2007


Page: 1 2 3

Related biology news :

1. EPA foregoes opportunity to improve nanotechnology oversight
2. Several minute intermediate stage in virus-cell fusion discovered; opportunity for drug development
3. Not-for-profit publishers call NIH public access rule a missed opportunity
4. The opportunity for canalization and the evolution of genetic networks
5. New molecular regulators of hyperthyroidism and goiter
6. Carnegie Mellon researchers urge regulators to rethink strategies for soot emission
7. New regulators of apoptosis and chemoresistance identified
8. Puberty onset influence of nutritional, environmental and endogenous regulators?
9. New technique for tracking gene regulators
10. AACR, FDA and NCI announce cancer biomarkers collaborative at the AACR 2007 annual meeting
11. Second annual stem cell symposium to focus on heart tissue, blood diseases

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/4/2020)... ... March 04, 2020 , ... The Massachusetts Medical Device Industry ... IGNITE program’s 2020 IGNITE Cohort. The MedTech IGNITE Program is a virtual accelerator ... next generation of medtech founders and entrepreneurs. IGNITE Cohort members get access to ...
(Date:3/2/2020)... ... ... Toronto-based clinical research organization (CRO) and regulatory consulting firm, dicentra , has ... of Clarksburg on a farm on Beaver Valley Road. , The owners currently operate ... decided it would be a great new option for employees to relocate to. , ...
(Date:2/28/2020)... , ... February 26, 2020 ... ... that its patent-pending Rebound PRP™ and Rebound PRF® devices are now available ... new generation of regenerative medical devices, that will provide the most affordable, ...
Breaking Biology News(10 mins):
(Date:2/21/2020)... ... , ... Pharmaceutical manufacturers are under increasing pressure to fast-track ... approaches like ‘Industry 4.0’ and continuous manufacturing, combat the growing and intense competition ... with an industry with the world’s tightest regulations and complex value chains, what ...
(Date:2/13/2020)... , ... February 12, 2020 , ... ... pharmacovigilance (PV) solutions and services, is adopting Veeva Vault Safety™ as ... a requirement for fast assessment of data, processing of safety information such as ...
(Date:2/5/2020)... FARMINGTON, Conn. (PRWEB) , ... February 04, 2020 ... ... that develops tools for characterizing microbiome populations down to the strain level, has ... Limited, will sell Shoreline Biome’s microbiome kits and other products to companies and ...
(Date:1/28/2020)... ... January 28, 2020 , ... ... the exclusive distributor to food and beverage manufactures within North America. Both Lifecycle ... suppliers. This agreement will allow each company to pool their collective resources and ...
Breaking Biology Technology:
Cached News: